Please Note: This trial is no longer enrolling new participants
A Phase III Double Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
| Protocol No. | E4512 | Scope | National |
|---|---|---|---|
| Principal Investigator | Shadia Jalal | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase III |
